Fischer Medical Ventures has closed its trading window for promoters, directors, and designated persons. This standard procedure is a safeguard against insider trading prior to the announcement of the financial results for the quarter. The restriction extends to their immediate relatives and will be lifted 48 hours after the results are publicly declared. This move aims to ensure fair disclosure and maintain market integrity for all stakeholders.